Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.
OPEN Psychological medicine | 22 Jun 2012
BR Godlewska, R Norbury, S Selvaraj, PJ Cowen and CJ Harmer
Abstract
Antidepressant drugs such as selective serotonin re-uptake inhibitors (SSRIs) remediate negative biases in emotional processing in depressed patients in both behavioural and neural outcome measures. However, it is not clear if these effects occur before, or as a consequence of, changes in clinical state. Method In the present study, we investigated the effects of short-term SSRI treatment in depressed patients on the neural response to fearful faces prior to clinical improvement in mood. Altogether, 42 unmedicated depressed patients received SSRI treatment (10 mg escitalopram daily) or placebo in a randomised, parallel-group design. The neural response to fearful and happy faces was measured on day 7 of treatment using functional magnetic resonance imaging. A group of healthy controls was imaged in the same way.
- Tweets*
- 4
- Facebook likes*
- 0
- Reddit*
- 0
- News coverage*
- 0
- Blogs*
- 1
- SC clicks
- 1
- Concepts
- Citalopram, Fluoxetine, Major depressive disorder, Sertraline, Tricyclic antidepressant, Serotonin, Antidepressant, Selective serotonin reuptake inhibitor
- MeSH headings
- -
comments powered by Disqus
* Data courtesy of Altmetric.com